Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 2.29M | $11.0M | 1.32% | -- | 2026-06-30 |
| Vivo Capital, LLC | 763.2K | $3.0M | 0.44% | -- | 2026-06-30 |
| GENERAL AMERICAN INVESTORS CO INC | 354.4K | $1.0M | 0.20% | -- | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 135.2K | -- | 0.08% | -- | 2026-06-30 |
| WELLS FARGO & COMPANY/MN | 77.2K | -- | 0.04% | -815 | 2026-06-30 |
| MORGAN STANLEY | 56.2K | -- | 0.03% | +9.3K | 2026-06-30 |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 45.1K | -- | 0.03% | +19.9K | 2026-06-30 |
| CITADEL ADVISORS LLC | 20.3K | -- | 0.01% | -3.2K | 2026-06-30 |
| XTX Topco Ltd | 15.2K | -- | 0.01% | +4.5K | 2026-06-30 |
| VSM Wealth Advisory, LLC | 10.0K | -- | 0.01% | -- | 2026-06-30 |
